tag sanofi 
Insulin Nation
MARCH 26, 2020
Sanofi, NovoNordisk, and Lilly have created huge and profitable businesses by filing hundreds of patents for every type of insulin in order to prevent generics from being legally possible. These critical therapies often carry a heavy price tag; the cost of insulin has risen over the past decade.
Lloyd Price
JULY 5, 2018
France-based Sanofi plunked down $11.6 That deal gave Sanofi two hemophilia drugs Eloctate for Hemophilia A and Alprolix for Hemophilia B. In January Sanofi also gained control of fitusiran, an RNAi therapeutic in development for hemophilia A and B through its partnership with Alnylam. One week later, Sanofi dropped another $4.8
Insulin Nation
OCTOBER 4, 2016
Here are some highlights of her plan , focusing on what might have the greatest impact to lower the price-tag on insulin: A $250 cap on monthly out-of-pocket expenses for prescription drug costs.
Expert insights. Personalized for you.
105 
Let's personalize your content